Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 1;8(3):235-243.
doi: 10.1093/jpids/piy035.

Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection

Affiliations

Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection

Tamara D Simon et al. J Pediatric Infect Dis Soc. .

Abstract

Background: Previous studies of cerebrospinal fluid (CSF) shunt infection treatment have been limited in size and unable to compare patient and treatment characteristics by infecting organism. Our objective was to describe variation in patient and treatment characteristics for children with first CSF shunt infection, stratified by infecting organism subgroups outlined in the 2017 Infectious Disease Society of America's (IDSA) guidelines.

Methods: We studied a prospective cohort of children <18 years of age undergoing treatment for first CSF shunt infection at one of 7 Hydrocephalus Clinical Research Network hospitals from April 2008 to December 2012. Differences between infecting organism subgroups were described using univariate analyses and Fisher's exact tests.

Results: There were 145 children whose infections were diagnosed by CSF culture and addressed by IDSA guidelines, including 47 with Staphylococcus aureus, 52 with coagulase-negative Staphylococcus, 37 with Gram-negative bacilli, and 9 with Propionibacterium acnes. No differences in many patient and treatment characteristics were seen between infecting organism subgroups, including age at initial shunt, gender, race, insurance, indication for shunt, gastrostomy, tracheostomy, ultrasound, and/or endoscope use at all surgeries before infection, or numbers of revisions before infection. A larger proportion of infections were caused by Gram-negative bacilli when antibiotic-impregnated catheters were used at initial shunt placement (12 of 23, 52%) and/or subsequent revisions (11 of 23, 48%) compared with all other infections (9 of 68 [13%] and 13 of 68 [19%], respectively). No differences in reinfection were observed between infecting organism subgroups.

Conclusions: The organism profile encountered at infection differs when antibiotic-impregnated catheters are used, with a higher proportion of Gram-negative bacilli. This warrants further investigation given increasing adoption of antibiotic-impregnated catheters.

Keywords: antibiotic; antibiotic-impregnated catheter; cerebrospinal; infection; shunt.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study cohort.
Figure 2.
Figure 2.
Antibiotic susceptibility profiles for all infection cases, with and without prior antibiotic-impregnated catheter (AIC) use. Lighter color denotes either equally split between sensitive and not sensitive, or that sensitivity was rarely tested.

References

    1. Kestle JR. Pediatric hydrocephalus: current management. Neurol Clin 2003; 21:883–95, vii. - PubMed
    1. Kulkarni AV, Riva-Cambrin J, Butler J, et al. Outcomes of CSF shunting in children: comparison of Hydrocephalus Clinical Research Network cohort with historical controls: clinical article. J Neurosurg Pediatr 2013; 12:334–8. - PubMed
    1. Piatt JH Jr, Carlson CV. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg 1993; 19:233–41; discussion 242. - PubMed
    1. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001; 94:195–201. - PubMed
    1. McGirt MJ, Leveque JC, Wellons JC 3rd, et al. Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg 2002; 36:248–55. - PubMed

Substances